The study of resistin and visfatin offers not just deeper insights into the intricate interplay between obesity and cancer but also serves as a reminder that every molecule in our body harbors a story waiting to be told—a story that could potentially revolutionize medicine. The gene discussed is NAMPT; the disease is obesity due to melanocortin 4 receptor deficiency.